Navigation Links
LCT and Otsuka of Japan Share Common DIABECELL(R) Vision
Date:4/12/2011

han 30 June 2011. Assuming shareholder approval of the conversion of the Note is obtained, the Note will automatically convert into 6,000,000 ordinary shares in LCT on the next business day after the date on which shareholder approval is obtained. If shareholder approval for the conversion of Note into Ordinary Shares is not obtained, the Note is repayable together with interest at the rate of 7.5% per annum on 31 December 2011.

About Living Cell Technologies - www.lctglobal.com

Living Cell Technologies (LCT) is developing cell-based products to treat life threatening human diseases. The Company owns a biocertified pig herd that it uses as a source of cells for treating diabetes and neurological disorders. For patients with Type 1 diabetes, the Company transplants microencapsulated islet cells so that near-normal blood glucose levels may be achieved without the need for administration of insulin or at significantly reduced levels. The Company entered clinical trials for its diabetes product in 2007. For the treatment of Parkinson's disease and other neurological disorders, the company transplants microencapsulated choroid plexus cells that deliver beneficial proteins and neurotrophic factors to the brain. LCT's technology enables healthy living cells to be injected into patients to replace or repair damaged tissue without requiring the use of immunosuppressive drugs to prevent rejection. LCT also offers medical-grade porcine-derived products for the repair and replacement of damaged tissues, as well as for research and other purposes.

About Otsuka Pharmaceutical Factory - www.otsukakj.jp/en/

Otsuka Pharmaceutical Factory, Inc., the first company in the Otsuka Group, was established by Busaburo Otsuka in 1921. Originally, the company manufactured and distributed industrial and pharmaceutical chemicals. It began manufacturing intravenous solutions
'/>"/>

SOURCE LCT
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. National Pharmaceutical Council Welcomes New Member, Otsuka America Pharmaceutical, Inc.
2. Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration
3. BioWa Announces Second Japanese License of POTELLIGENT(R) Technology to Otsuka Pharmaceutical
4. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
5. Aribex and IDENS Donate 15 Victim I.D. Kits for Japan
6. Volcano Announces the Introduction of the PrimeWire PRESTIGE® Pressure Guide Wire in Japan
7. MSA Increases Production of Air-Purifying Respirators to Help Meet Increased Demand from Japan
8. PromiseCare Pharmacy Donates to Soles4Souls® Japanese Relief Efforts
9. Heyltex Corporation Working With United States and Japan to Add Production of Radiological Antidotes
10. Medco Foundation Donates $100,000 to Red Cross for Japanese Earthquake and Pacific Tsunami Relief
11. Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014  Decision Resources Group finds that ... (ID) specialists are willing to prescribe Durata,s Dalvance ... use as OPAT, approximately two-thirds of the respondents ... their hospital inpatients. However, our findings indicate that ... initiated on OPAT following hospital discharge, and most ...
(Date:7/10/2014)... July 10, 2014 CVS Caremark Corporation (NYSE: ... has approved a quarterly dividend of $0.275 (27.5 cents) per ... on August 1, 2014, to holders of record on July ... CVS Caremark is dedicated to helping people on their path ... the United States . Through the company,s ...
(Date:1/15/2014)... Jan. 15, 2014 Sono-Tek Corporation (OTC BB: SOTK) today ... 30, 2013, compared to sales of $2,202,000 for the prior ... this quarter has also shown growth over the preceding quarter,s ... of this fiscal year. Markets that experienced sales increases over ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4
... Mass., Jan. 4, 2012  Halo Therapeutics, LLC, a ... fibrotic diseases, today announced that the United States ... designation for HT-100 for treatment of Duchenne muscular ... neuromuscular disorder, which afflicts approximately 1 in 3,500 ...
... Pa., Jan. 4, 2012  Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) ... 30th Annual J.P. Morgan Healthcare Conference to be held ... in San Francisco, CA.  Mr. Adrian Adams, Chief Executive ... of the Company and its product pipeline at 2:00 ...
Cached Medicine Technology:Halo Therapeutics' HT-100 Receives FDA's Orphan Designation for Duchenne Muscular Dystrophy 2Halo Therapeutics' HT-100 Receives FDA's Orphan Designation for Duchenne Muscular Dystrophy 3Auxilium Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference 2Auxilium Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference 3Auxilium Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference 4
(Date:7/11/2014)... MagicQuinceaneraDresses.com, the popular online supplier of special occasion gowns, ... dresses . The company’s new items are specially designed ... a large amount of money. They are all available ... company’s online shop has become a one stop platform ... addition to exquisite Quinceanera dresses, it also offers great ...
(Date:7/11/2014)... July 12, 2014 According to ... total market is expected to register a CAGR ... , Browse 71 market data tables and 76 ... on "C4ISR Market"., http://www.marketsandmarkets.com/Market-Reports/c4isr-market-1315.html , Early ... http://www.marketsandmarkets.com/requestCustomization.asp?id=1315 , The report provides market ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Butler Mobility has ... Inclined Platform Lifts . Previously the two standard ... five new beautiful earth tone colors as standard colors at ... well in the home but will enhance the beauty of ... for any home color scheme or individual décor. , The ...
(Date:7/11/2014)... Dennis Thompson HealthDay Reporter ... born with HIV who was thought to be cured by ... showing detectable levels of the AIDS-causing virus in her bloodstream, ... nearly 4 years old, had remained virus-free even though she ... Doctors had hoped her remission would open the door to ...
(Date:7/11/2014)... As part of its morcellator ... has been closely monitoring the ongoing meeting of ... Obstetrics and Gynecology Devices Panel, which has been ... risks associated with the use of power morcellators ... report published by Dow Jones Business News, a ...
Breaking Medicine News(10 mins):Health News:Cheap Quinceanera Dresses Now Available At MagicQuinceaneraDresses.com 2Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 2Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 3Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Butler Mobility Products Announces Five New Standard Colors for Their Inclined Platform Lifts 2Health News:Mississippi Girl Thought Cured of HIV Shows Signs of Infection 2Health News:Mississippi Girl Thought Cured of HIV Shows Signs of Infection 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 4
... evading the drugs used by oncologists to try and eliminate it. ... , Now, researchers at UCLA,s Jonsson Comprehensive ... around an inhibitor, Zelboraf, which targets the mutated BRAF gene. ... encodes proteins, called the exome, Jonsson Cancer Center scientists discovered that ...
... Cancer Center and colleagues from 11 other institutions in the ... association studies (GWAS) one from the U.S. and one ... genes found to be associated with epithelial ovarian cancer patient ... for treating epithelial ovarian cancer (EOC), the most lethal kind ...
... from Carnegie Mellon University,s Marcel Just provides an explanation ... communication disorders to restricted interests and gives scientists ... Autism has long been a scientific enigma, mainly due ... Published in the journal Neuroscience and Biobehavioral ...
... 2012 Married adults who undergo heart surgery are more ... the same surgery to survive the next three months, a ... survival rates for single people, during the most critical post-operative ... and lead author of the study, which appears in the ...
... the metabolic syndromedefined as having multiple risk factors associated ... of chronic kidney disease, according to a recent study ... of Clinical Endocrinology & Metabolism (JCEM). An ... have three or more of the following risk factors ...
... People with schizophrenia report improved functioning after ... to results announced today from a six-month pilot. ... People with Schizophrenia , was spearheaded by the ... and administered at 10 community behavioral health organizations ...
Cached Medicine News:Health News:UCLA scientists uncover mechanism for melanoma drug resistance 2Health News:UCLA scientists uncover mechanism for melanoma drug resistance 3Health News:Researchers find possible genetic keys to surviving epithelial ovarian cancer 2Health News:New brain imaging and computer modeling predicts autistic brain activity and behavior 2Health News:New brain imaging and computer modeling predicts autistic brain activity and behavior 3Health News:Marriage: A powerful heart drug in short supply 2Health News:High blood glucose levels may increase kidney disease in elderly populations 2Health News:Pilot program demonstrates measureable benefits for people with schizophrenia 2
... includes three major components: Blood pump, Cannulae, ... Driver. This system provides partial or total ... conventional therapy, is unable to maintain adequate ... support, blood flows from the natural heart ...
Datascope presents a unique new product for post-hemostasis puncture site management. Safeguard is the first product ever to combine a built-in inflatable bulb and a sterile dressing- providing adjus...
... catheter is inserted into the subclavian or ... vena cava. The Cool Line incorporates ... temperature-controlled saline flowing within a closed-loop design, ... circulation. The Cool Line combines two ...
... The Fortius catheter provides maximum ... to target temperature. The Fortius catheter ... design to provide the ultimate solution ... catheter is inserted percutaneously into the ...
Medicine Products: